Home / Brands / Tailstorm Health
Tailstorm Health Recalls
8 recalls on record · July 17, 2024 to July 9, 2025 · Drugs
Recalls by year
24
25
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
July 9, 2025DrugsFDA
Tailstorm Health INC recalls LIDOcaine HCL Sterile Injection, USP, 20 mg/mL, 2%, (200 mg/10 mL), For Infiltration & Nerve Block, Including Caudal & E
Hazard: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
July 9, 2025DrugsFDA
Tailstorm Health INC recalls LIDOcaine HCL Sterile Injection, USP, 100mg/10mL, 1%, (10mg/mL), w/EPINEPHRINE 1:100,000, For Infiltration & Nerve Block
Hazard: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
July 9, 2025DrugsFDA
Tailstorm Health INC recalls KETAmine Hydrochloride Injection, USP, 500mg/5mL, (10mg/mL), For IM or Slow IV Use, 5mL Sterile Multi-Dose Vial, Rx Only
Hazard: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
July 9, 2025DrugsFDA
Tailstorm Health INC recalls KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, R
Hazard: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
July 9, 2025DrugsFDA
Tailstorm Health INC recalls BUPIVAcaine HCL Sterile injection, USP w/EPINEPHRINE 1:200,000, 50 mg/10mL, 0.5%, (5mg/mL), 10 mL Sterile Single-Dose Vi
Hazard: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
July 9, 2025DrugsFDA
Tailstorm Health INC recalls LIDOcaine HCl Injection, USP, 10mg/mL, 1% (100 mg/10mL), 10 mL Sterile Single Dose Vial, Rx Only, For Infiltration & Ner
Hazard: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.
November 27, 2024DrugsFDA
Tailstorm Health INC recalls BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Heal
Hazard: Lack of Sterility Assurance
July 17, 2024DrugsFDA
TAILSTORM HEALTH INC recalls Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Com
Hazard: Subpotent Drug: reduced efficacy for epinephrine